Ledipasvir is an antiviral drug you’ll usually see combined with sofosbuvir (the combo is commonly called Harvoni). It targets the NS5A protein of the hepatitis C virus (HCV), stopping the virus from copying itself. That makes it a core option for curing many people with genotype 1 HCV and some other genotypes when used as part of a full treatment plan.
The standard tablet combines ledipasvir 90 mg with sofosbuvir 400 mg and is taken once daily, often for 8 to 12 weeks depending on your medical situation. Your doctor decides the exact length based on things like prior treatment history, viral genotype, and whether you have cirrhosis. You’ll usually have blood tests during treatment — viral load checks at about 4 weeks, at the end of therapy, and around 12 weeks after finishing to confirm cure (called sustained virologic response or SVR).
Some quick, useful tips:
Most people tolerate ledipasvir/sofosbuvir well. The common side effects are fatigue, headache, and nausea. Serious problems are uncommon but can happen — report new dizziness, fainting, severe rash, or breathing trouble right away.
Watch for these interactions and issues:
If you have severe kidney disease or complex liver disease, dosing and safety need careful review. Sofosbuvir is processed by the kidneys, so kidney function affects decisions. Pregnant people or those breastfeeding should discuss risks and timing with their clinician.
Want to know more? Ask your doctor or pharmacist for a clear plan: how long you’ll take treatment, which tests you’ll need, and what to do about other medicines. Ledipasvir isn’t sold over the counter — it requires a prescription and medical follow-up to make sure the infection is cured safely.
Written by :
Zachary Kent
Categories :
Medications
Tags :
ledipasvir
drug-induced liver injury
potential
hepatotoxicity
I recently came across some fascinating information about Ledipasvir, a medication used to treat hepatitis C. While it's undoubtedly effective in combating the virus, there's growing concern about its potential to cause drug-induced liver injury. This is quite alarming since the liver is already compromised in hepatitis C patients. As a result, it's crucial that healthcare professionals closely monitor patients receiving Ledipasvir to ensure their liver functions remain stable. In conclusion, while Ledipasvir has its benefits, it's essential to be aware of the potential risks and take necessary precautions.
© 2025. All rights reserved.